fill
Listen On
Gastroenterology

Is there a correlation of myeloid cells expressing CD64 and endoscopy disease severity?

Amy Stewart, NP, from Capital Digestive Care, explores the correlation between CD64-positive myeloid cells and endoscopic disease severity in IBD. Learn how these immune cells contribute to inflammation in Crohn's disease and their role in guiding treatment decisions.

Related FAQ Video Module

faqimg

What role does a new mechanism of action play in your prescribing decisions of IBS-C therapy?

faqimg

What is the Difference Between Biosimilars and Generics?

faqimg

What does it mean for a biosimilar to be interchangeable and why is that important?

faqimg

Provide immunologic rationale for IL23 directed therapy in IBD

faqimg

What resources do you use to understand the latest approaches to managing IBS-C patients?

faqimg

What is the role of IL23/IL17 axis in IBD

faqimg

Why is binding CD64+ important when discussing IL23 directed therapy?

faqimg

Best practices in determining clinically meaningful “response” to therapy for IBS-C patients?

faqimg

Describe the IL23/IL17 axis

faqimg

Best practices to accelerate the time to finding the right therapy for your patients with IBS-C?

VIEW ALL
sectionimg
dotimg

Download the app and start using it now

appstore Download on the App Store playstore GET IT ON Google Play

© 2025 Gastroenterology & Hepatology Advance Practice Providers, All rights reserved.